enkephalin, ser(2), leu(5), thr(6)- has been researched along with 7-spiroindanyloxymorphone in 2 studies
| Studies (enkephalin, ser(2), leu(5), thr(6)-) | Trials (enkephalin, ser(2), leu(5), thr(6)-) | Recent Studies (post-2010) (enkephalin, ser(2), leu(5), thr(6)-) | Studies (7-spiroindanyloxymorphone) | Trials (7-spiroindanyloxymorphone) | Recent Studies (post-2010) (7-spiroindanyloxymorphone) |
|---|---|---|---|---|---|
| 224 | 0 | 5 | 12 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moe, ST; Portoghese, PS; Takemori, AE | 1 |
| Bernard, D; Coop, A; MacKerell, AD | 1 |
2 other study(ies) available for enkephalin, ser(2), leu(5), thr(6)- and 7-spiroindanyloxymorphone
| Article | Year |
|---|---|
A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Guinea Pigs; Male; Mice; Muscle, Smooth; Oxymorphone; Receptors, Opioid, delta; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Vas Deferens | 1993 |
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.
Topics: Animals; Cell Line, Tumor; Enkephalin, Leucine; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Conformation; Phenylalanine; Quantitative Structure-Activity Relationship; Rats; Receptors, Opioid, delta | 2007 |